Kestra Private Wealth Services LLC lessened its stake in CME Group Inc. (NASDAQ:CME – Get Rating) by 4.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,786 shares of the financial services provider’s stock after selling 87 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in CME Group were worth $425,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also recently made changes to their positions in CME. Bromfield Sneider Wealth Advisors purchased a new stake in shares of CME Group during the 1st quarter valued at about $26,000. Power Corp of Canada purchased a new position in shares of CME Group during the 1st quarter worth $26,000. IndexIQ Advisors LLC purchased a new stake in shares of CME Group in the 1st quarter worth $27,000. Cornerstone Advisory LLC bought a new position in CME Group in the 4th quarter worth $29,000. Finally, MayTech Global Investments LLC purchased a new position in CME Group during the first quarter valued at $36,000. Institutional investors own 85.56% of the company’s stock.
CME Group Price Performance
Shares of CME stock opened at $190.72 on Tuesday. CME Group Inc. has a twelve month low of $185.79 and a twelve month high of $256.94. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a fifty day simple moving average of $199.93 and a two-hundred day simple moving average of $211.62. The stock has a market capitalization of $68.55 billion, a price-to-earnings ratio of 23.77, a P/E/G ratio of 3.09 and a beta of 0.40.
CME Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 27th. Investors of record on Friday, September 9th will be paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 2.10%. The ex-dividend date is Thursday, September 8th. CME Group’s dividend payout ratio (DPR) is 49.63%.
Insiders Place Their Bets
In other news, insider Timothy Francis Mccourt sold 360 shares of the business’s stock in a transaction on Monday, September 19th. The stock was sold at an average price of $190.77, for a total value of $68,677.20. Following the completion of the transaction, the insider now directly owns 5,431 shares of the company’s stock, valued at approximately $1,036,071.87. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other CME Group news, insider Hilda Harris Piell sold 4,901 shares of the stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $203.88, for a total value of $999,215.88. Following the completion of the sale, the insider now directly owns 33,140 shares in the company, valued at $6,756,583.20. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Timothy Francis Mccourt sold 360 shares of CME Group stock in a transaction that occurred on Monday, September 19th. The stock was sold at an average price of $190.77, for a total transaction of $68,677.20. Following the completion of the sale, the insider now owns 5,431 shares of the company’s stock, valued at $1,036,071.87. The disclosure for this sale can be found here. Insiders sold a total of 10,511 shares of company stock worth $2,123,186 over the last 90 days. Company insiders own 0.30% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on CME. Credit Suisse Group decreased their price objective on CME Group from $216.00 to $210.00 and set a “neutral” rating on the stock in a research note on Tuesday, September 6th. Morgan Stanley reduced their price objective on shares of CME Group from $242.00 to $226.00 and set an “equal weight” rating for the company in a research note on Thursday, July 28th. Oppenheimer upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $223.00 target price on the stock in a research note on Wednesday, May 25th. Rosenblatt Securities started coverage on CME Group in a report on Tuesday, August 16th. They set a “sell” rating and a $171.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on CME Group from $208.00 to $212.00 and gave the stock a “hold” rating in a research note on Friday, August 12th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $230.80.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
- Get a free copy of the StockNews.com research report on CME Group (CME)
- Oracle’s Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin’ It: Investors Keep Visiting McDonald’s
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.